Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on July 23, 2025
WellSpan officials celebrate progress in construction of 3 WellSpan hospitals
GlobeNewswire
·
July 23, 2025
York, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- The construction of three WellSpan hospitals has reached a significant milestone, with the final beams going up as the buildout of these innovative hospitals in central Pennsylvania enters its final stages. …
CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc.
GlobeNewswire
·
July 23, 2025
CALABASAS, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- In a press release issued earlier today by NeOnc Technologies Holdings, Inc. under the headline, "NeOnc Technologies’ Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com …
Paralyzed Veterans of America Discusses 35th Anniversary of Americans with Disabilities Act (ADA) with YourUpdateTV
GlobeNewswire
·
July 23, 2025
Carl Blake, CEO of Paralyzed Veterans of America, conducts nationwide media tour in conjunction with D S Simon Media and YourUpdateTV to discuss the importance of this anniversary, efforts to address disability-related barriers, PVA’s new “Barriers Still …
NBME awarding fee assistance to more than 500 students this summer
GlobeNewswire
·
July 23, 2025
PHILADELPHIA, July 23, 2025 (GLOBE NEWSWIRE) -- As part of its commitment to provide $1 million in funding for medical students with financial need, NBME is accepting applications for its next cycle of the fee assistance program until Aug. 24, 2025. NBME’s …
AscellaHealth Service and Infrastructure Enhancements Support Specialty Drug Manufacturers to Protect Market Share Across Brand, Biosimilar and Generic Launches
GlobeNewswire
·
July 23, 2025
BERWYN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces service and infrastructure enhancements designed to help specialty and rare disease …
Unlocking Growth in the Consumer Packaged Goods Market: What’s Driving the 2030 Surge
GlobeNewswire
·
July 23, 2025
Delray Beach, FL, July 23, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets™, the consumer packaged goods (CPG) market size is on a steady growth path, projected to rise from USD 3,450.12 billion in 2025 to USD 4,235.01 billion by 2030, growing at a …
PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio
GlobeNewswire
·
July 23, 2025
MENLO PARK, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has joined the 1000 Genomes Long Read Sequencing Project, which will involve …
Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology
GlobeNewswire
·
July 23, 2025
July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major …
Inotrem Unveils Game-Changing Precision Medicine Strategy for Nangibotide Clinical Development in Septic Shock
GlobeNewswire
·
July 23, 2025
Inotrem Unveils Game-Changing Precision Medicine Strategy for Nangibotide Clinical Development in Septic Shock Published in Intensive Care Medicine, Inotrem’s results highlight the pivotal role of the soluble TREM-1 biomarker in identifying high-risk …
NeOnc Technologies’ Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com/@Floorstocks — Today at 11:00 a.m. ET
GlobeNewswire
·
July 23, 2025
CALABASAS, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI), a clinical-stage biotechnology company advancing transformative treatments for brain and central nervous system cancers, is pleased to announce that its …
Qu Biologics Completes Enrolment of a Unique Study Testing a Novel Immunomodulator to Restore Immune Function in the Elderly
GlobeNewswire
·
July 23, 2025
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate immune function, is …
Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company
GlobeNewswire
·
July 23, 2025
BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”) today announced the appointment of Kristin Yarema, Ph.D. as Chief Executive Officer of ImageneBio (“Imagene …
Akari Therapeutics Continues Key Research on its Novel Antibody Drug Conjugate Payload PH1 to Further Demonstrate its Unique Ability to Target Cancers Fueled by Oncogenic Drivers
GlobeNewswire
·
July 23, 2025
PH1 modulates RNA splicing, causing cancer cell death while activating the immune system to attack cancer throughout the body Company advancing pipeline of ADCs using PH1 payload across both Trop2 and an undisclosed target Emerging new preclinical data on …
Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder
GlobeNewswire
·
July 23, 2025
Vancouver, Canada, July 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Tenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive Officer
GlobeNewswire
·
July 23, 2025
SOUTH SAN FRANCISCO, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Tenvie Therapeutics, a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases, today announced the appointment of Tony Estrada, Ph. …
Windward Bio Initiates Global Phase 2 Asthma Trial of WIN378, a Potential Best-in-Disease, Long-Acting, Anti-TSLP Monoclonal Antibody
GlobeNewswire
·
July 23, 2025
Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of WIN378 in patients with asthma, with a first data readout expected in mid-2026 WIN378 has the potential to be the first-to-market long-acting, anti-TSLP antibody with twice-yearly …
Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience
GlobeNewswire
·
July 23, 2025
Data confirms Company’s ability to detect trace sweat volumes at ultra-micro level System demonstrates resilience across diverse conditions NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), …
Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025
GlobeNewswire
·
July 23, 2025
CAMBRIDGE, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference …
NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office
GlobeNewswire
·
July 23, 2025
Patent Strengthens Intellectual Property Portfolio Surrounding Neural Probe Technologies EDEN PRAIRIE, Minn., July 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology …
Alkeus Pharmaceuticals Announces Gildeuretinol Data Presentations During the American Society of Retina Specialists (ASRS) 43rd Annual Meeting July 29-August 2
GlobeNewswire
·
July 23, 2025
CAMBRIDGE, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that data from its clinical studies of …